Head of CMC @ BlackThorn Therapeutics (Acquired by Neumora) (January 2018 - June 2019)
Executive Director, Drug Substance Manufacturing and Development @ Relypsa (February 2016 - January 2018)
Senior Director, Drug Substance, Manufacturing and Development @ Relypsa (December 2012 - February 2016)
Director, Process Engineering @ (September 2010 - November 2012)
Associate Director, Process Engineering @ (March 2009 - September 2010)
Senior Research Scientist @ (August 2007 - March 2009)
Senior Research Investigator @ (August 2000 - July 2007)
Otute A Skills
Resource Management
Timelines
Strategic Planning
Good Laboratory Practice (GLP)
Manufacturing Operations
Validation (Drug Manufacture)
Regulatory Affairs
Standard Operating Procedure (SOP)
Manufacturing Engineering
Laboratory Skills
Research Skills
Corrective and Preventive Action (CAPA)
Regulatory Submissions
Manufacturing
Process Validation
CFD
Process Modeling
Reaction Engineering
Technology Transfer
R&D
GMP
Process Simulation
Chemical Engineering
Process Analytical Technology
Pharmaceutical Industry
Pharmaceutical process development
V&V
Drug Discovery
Drug Development
Chemistry
Commercialization
FDA
Process Engineering
Quality by Design
Engineering
Biotechnology
Research and Development (R&D)
Otute A Summary
Otute A, based in San Francisco, CA, US, is currently a Vice President, CMC at Corvus Pharmaceuticals. Otute A brings experience from previous roles at Neumora, BlackThorn Therapeutics and BlackThorn Therapeutics (Acquired by Neumora). With a robust skill set that includes Resource Management, Timelines, Strategic Planning, Good Laboratory Practice (GLP), Manufacturing Operations and more. Otute A has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Otute A?
Find contact details for 700 million professionals.